[Safety profile of pariet clinical use (a literature review)].
Sheptulin
A A
AA
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000368:Aged; D001562:Benzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D005753:Gastric Mucosa / Q000187:drug effects / Q000473:pathology; D005755:Gastrins / Q000097:blood; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced; D009853:Omeprazole / Q000031:analogs & derivatives; D006180:Proton-Translocating ATPases / Q000037:antagonists & inhibitors*; D064750:Rabeprazole
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles; D004791:Enzyme Inhibitors; D005755:Gastrins; D064750:Rabeprazole; D006180:Proton-Translocating ATPases; D009853:Omeprazole